[Omeprazole of limited value in crying babies]

Area of Science:

• Pediatric Gastroenterology
• Pharmacology
• Evidence-Based Medicine

Context:

• Infantile crying is a common concern for parents and healthcare providers.
• Acid gastroesophageal reflux (GER) is often suspected as a cause of persistent crying in infants.
• Omeprazole, a proton pump inhibitor, is frequently used off-label for suspected GER in infants.

Purpose:

• To evaluate the role of omeprazole in treating crying infants under one year with suspected acid gastroesophageal reflux.
• To assess the efficacy, prescribing patterns, and side effects of omeprazole in this vulnerable population.
• To review existing literature and pharmacovigilance data regarding omeprazole use in infants.

Summary:

• Literature review found limited studies (3 clinical trials) on omeprazole efficacy in infants for crying. While it reduced stomach acidity, symptom improvement was not demonstrated.
• Prescribing data indicated challenges in appropriate dosing due to fixed dosages (10 mg), leading to potential under or overdosing.
• Few adverse drug reactions were reported to pharmacovigilance centers, but the potential for side effects exists.

Impact:

• The current evidence is insufficient to establish omeprazole as a preferred treatment for crying infants with suspected acid reflux.
• Highlights the need for more robust clinical trials to determine the true efficacy and safety profile of omeprazole in infant GER.
• Informs clinical practice regarding the cautious use of omeprazole in infants and the importance of considering alternative diagnoses for infantile crying.